Patient leaflet - Ambrisentan Mylan 10 mg film-coated tablets
1. What Ambrisentan Mylan is and what it is used for
Ambrisentan Mylan contains the active substance ambrisentan. It belongs to a group of medicines called other antihypertensives (used to treat high blood pressure).
It is used to treat pulmonary arterial hypertension (PAH) in adults. PAH is high blood pressure in the blood vessels (the pulmonary arteries) that carry blood from the heart to the lungs. In people with PAH, these arteries get narrower, so the heart has to work harder to pump blood through them. This causes people to feel tired, dizzy and short of breath.
Ambrisentan Mylan widens the pulmonary arteries, making it easier for the heart to pump blood through them.
This lowers the blood pressure and relieves the symptoms.
Ambrisentan Mylan may also be used in combination with other medicines used to treat PAH.
2. What you need to know before you take Ambrisentan Mylan
Do not take Ambrisentan Mylan:
- if you are allergic to ambrisentan or any of the other ingredients of this medicine (listed in section 6).
- if you are pregnant, if you are planning to become pregnant, or if you could become pregnant because you are not using reliable birth control (contraception). Please read the information under ‘Pregnancy’
- if you are breast feeding. Read the information under ‘Breast-feeding’
- if you have liver disease. Talk to your doctor, who will decide whether this medicine is suitable for you
- if you have scarring of the lungs, of unknown cause (idiopathic pulmonary fibrosis).
Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking this medicine if you have:
- liver problems
- anaemia (a reduced number of red blood cells)
- swelling in the hands, ankles or feet caused by fluid (peripheral oedema)
- lung disease where the veins in the lungs are blocked (pulmonary veno-occlusive disease).
Your doctor will decide whether Ambrisentan Mylan is suitable for you.
You will need regular blood tests
Before you start taking Ambrisentan Mylan, and at regular intervals while you’re taking it, your doctor will take blood tests to check:
- whether you have anaemia
- whether your liver is working properly.
It is important that you have these regular blood tests for as long as you are taking Ambrisentan Mylan.
Signs that your liver may not be working properly include:
- loss of appetite
- feeling sick (nausea)
- being sick (vomiting)
- high temperature (fever)
- pain in your stomach (abdomen)
- yellowing of your skin or the whites of your eyes (jaundice)
- dark-coloured urine
- itching of your skin.
If you notice any of these signs:
- Tell your doctor immediately.
Children and adolescents
Ambrisentan Mylan is not recommended for children and adolescents aged under 18 years as the safety and effectiveness is not known in this age group.
Other medicines and Ambrisentan Mylan
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Your doctor may need to adjust your dose of Ambrisentan Mylan if you start taking cyclosporine A (a medicine used after transplant or to treat psoriasis).
If you’re taking rifampicin (an antibiotic used to treat serious infections) your doctor will monitor you when you first start taking Ambrisentan Mylan.
If you’re taking other medicines used to treat PAH (e.g. iloprost, epoprostenol, sildenafil) your doctor may need to monitor you.
Tell your doctor or pharmacist if you are taking any of these medicines.
Pregnancy
Ambrisentan Mylan may harm unborn babies conceived before, during or soon after treatment.
If it is possible you could become pregnant, use a reliable form of birth control (contraception) while you’re taking Ambrisentan Mylan. Talk to your doctor about this.
Don’t take Ambrisentan Mylan if you are pregnant or planning to become pregnant.
If you become pregnant or think that you may be pregnant while you’re taking Ambrisentan Mylan, see your doctor immediately.
If you are a woman who could become pregnant, your doctor will ask you to take a pregnancy test before you start taking Ambrisentan Mylan and regularly while you are taking this medicine.
Breast‑feeding
It is not known if Ambrisentan Mylan is transferred to breast milk.
Don’t breast‑feed while you’re taking Ambrisentan Mylan. Talk to your doctor about this.
Fertility
If you are a man taking Ambrisentan Mylan, it is possible that this medicine may lower your sperm count. Talk to your doctor if you have any questions or concerns about this.
Driving and using machines
Ambrisentan Mylan may cause side effects, such as low blood pressure, dizziness, tiredness (see section 4), that may affect your ability to drive or use machines. The symptoms of your condition can also make you less fit to drive or use machines.
Don’t drive or use machines if you’re feeling unwell.
Ambrisentan Mylan tablets contains lactose and Allura red (E129)
Ambrisentan Mylan tablets contain small amounts of a sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars:
Contact your doctor before taking this medicinal product.
Ambrisentan Mylan tablets contain a colouring agent called Allura red AC Aluminium Lake (E129) which may cause allergic reactions.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
3. How to take Ambrisentan Mylan
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
How much Ambrisentan Mylan to take
The usual dose of Ambrisentan Mylan is one 5 mg tablet, once a day. Your doctor may decide to increase your dose to 10 mg, once a day.
[ Page # 1 of 2 ]
Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks 01.11.2022 - KLD SHARED
Date / Remarks
Date / Remarks
dd / mm / yy dd / mm / yy 1 of 2
Die Line
NA
100%
14/04/23 15:20 ART-31365-01
ART-31365-01
NA
NA
PLGB 04569/2027, PLGB 04569/2028
400573579, 400573578
Mylan Laboratories Ltd ( Nashik IN)
NA
698229
3
NA
NA
Myriad Pro
NA
9 pt
New Component for BR-GB
NA
NA
Adobe Indesign 2020 United Kingdom (GB)
LIT. (B/F) AMBRISENTAN MYLAN TABS (COMMON) BR-GB
75093874
NIL
Printed Literature
1
Folded size - 140 x 40 mm
NA
NA
NA
40 gsm ITC Tribeni Paper
If you take cyclosporine A, do not take more than one 5 mg tablet of Ambrisentan Mylan once a day.
How to take Ambrisentan Mylan
It is best to take your tablet at the same time each day. Swallow the tablet whole, with a glass of water, do not split, crush or chew the tablet. You can take Ambrisentan Mylan with or without food.
If you take more Ambrisentan Mylan than you should
If you take too many tablets you may be more likely to have side effects, such as headache, flushing, dizziness, nausea (feeling sick), or low blood pressure that could cause light-headedness:
Ask your doctor or pharmacist for advice if you take more tablets than prescribed.
If you forget to take Ambrisentan Mylan
If you forget a dose of Ambrisentan Mylan, just take the tablet as soon as you remember, then carry on as before.
Don’t take two doses at the same time to make up for a forgotten dose.
Don’t stop taking Ambrisentan Mylan without your doctor’s advice.
Ambrisentan Mylan is a treatment that you will need to keep on taking to control your PAH.
Don’t stop taking Ambrisentan Mylan unless you have agreed this with your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Conditions you and your doctor need to look out for:
Allergic reactions
This is a common side effect that may affect up to one in 10 people. You may notice a rash or itching and swelling (usually of the face, lips, tongue or throat), which may cause difficulty in breathing or swallowing.
Swelling (oedema), especially of the ankles and feet
This is a very common side effect that may affect more than one in 10 people.
Heart failure
This is due to the heart not pumping out enough blood, causing shortness of breath, extreme tiredness and swelling in the ankles and legs. This is a common side effect that may affect up to one in 10 people.
Anaemia (reduced number of red blood cells)
This is a blood disorder which can cause tiredness, weakness, shortness of breath, and generally feeling unwell. Sometimes this requires a blood transfusion. This is a very common side effect that may affect more than one in 10 people.
Hypotension (low blood pressure)
This can cause light-headedness. This is a common side effect that may affect up to one in 10 people.
Tell your doctor straight away if you get these effects or if they happen suddenly after taking Ambrisentan Mylan.
It is important to have regular blood tests,
to check for anaemia and that your liver is working properly. Make sure that you have also read the information in section 2 under ‘You will need regular blood tests’ and ‘Signs that your liver may not be working properly’.
Other side effects include
Very common side effects:
- headache
- dizziness
- palpitations (fast or irregular heart-beats)
- worsening shortness of breath shortly after starting Ambrisentan Mylan
- a runny or blocked nose, congestion or pain in the sinuses
- feeling sick (nausea)
- diarrhoea
- feeling tired
In combination with tadalafil (another PAH medicine) in addition to the above:
- flushing (redness of the skin)
- being sick (vomiting)
- chest pain/discomfort.
Common side effects:
- blurry or other changes to vision
- fainting
- abnormal blood test results for liver function
- a runny nose
- constipation
- pain in your stomach (abdomen)
- chest pain or discomfort
flushing (redness of the skin)
- being sick (vomiting)
- feeling weak
- nose bleed
- rash
In combination with tadalafil
In addition to the above, except abnormal blood test results for liver function:
- ringing in the ears (tinnitus) only when taking the combination treatment.
Uncommon side effects:
- liver injury
- inflammation of the liver caused by the body’s own defences (autoimmune hepatitis)
In combination with tadalafil:
- sudden hearing loss.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Ambrisentan Mylan
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP.
The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Ambrisentan Mylan contains
The active substance is ambrisentan. Each film-coated tablet contains 5 mg or 10 mg.
The other ingredients are lactose, see section 2, ‘Ambrisentan Mylan contains lactose’, microcrystalline cellulose (E460i), sodium croscarmellose, magnesium stearate (E570), polyvinyl alcohol part hydrolysed, titanium dioxide (E171), macrogol/PEG, talc (E553b), Allura red (E129), see section 2 ‘Ambrisentan Mylan contains Allura red (E129)’, Indigo carmine (E132)
What Ambrisentan Mylan looks like and contents of the pack
Ambrisentan Mylan 5 mg film-coated tablet (tablet) is a pink round biconvex tablet engraved with ‘M’ on one side and ‘AN’ on the other side.
Ambrisentan Mylan 10 mg film-coated tablet (tablet) is a pink, capsule shaped tablet engraved with ‘M’ on one side of the tablet and ‘AN1’ on the other side.
Ambrisentan Mylan is supplied as 5 mg and 10 mg film-coated tablets in packs of 30 tablets and unit dose blister packs of 30x1 tablets or 60 x1 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Mylan,
Potters Bar,
EN6 1TL,
United Kingdom.
Manufacturer
Gerard Laboratories,
35/36 Baldoyle Industrial Estate,
Grange Road,
Dublin 13,
Ireland.
Mylan Germany GmbH,
Zweigniederlassung Bad Homburg v. d., Hoeh,
Benzstrasse 1,
61352 Bad Homburg v. d. Hoehe,
Germany.
Mylan Hungary Kft,
Mylan utca 1,
2900 Komárom,
Hungary.
This leaflet was last revised in April 2023.
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
ART-31365-01
75093874
[ Page # 2 of 2 ]
Date / Remarks
Date / Remarks
Date / Remarks
Date / Remarks
Date / Remarks Date / Remarks Date / Remarks Date / Remarks 01.11.2022 - KLD SHARED
Date / Remarks
Date / Remarks
dd / mm / yy dd / mm / yy 2 of 2
Die Line
NA
100%
14/04/23 15:20 ART-31365-01
ART-31365-01
NA
NA
PLGB 04569/2027, PLGB 04569/2028
400573579, 400573578
Mylan Laboratories Ltd ( Nashik IN)
NA
698229
3
NA
NA
Myriad Pro
NA
9 pt
New Component for BR-GB
NA
NA
Adobe Indesign 2020 United Kingdom (GB)
LIT. (B/F) AMBRISENTAN MYLAN TABS (COMMON) BR-GB
75093874
NIL
Printed Literature
1
Folded size - 140 x 40 mm
NA
NA
NA
40 gsm ITC Tribeni Paper